Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes
- 15 January 2011
- Vol. 29 (11) , 2110-2119
- https://doi.org/10.1016/j.vaccine.2010.12.131
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Enhanced Induction of HIV-specific Cytotoxic T Lymphocytes by Dendritic Cell-targeted Delivery of SOCS-1 siRNAMolecular Therapy, 2010
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationProceedings of the National Academy of Sciences, 2010
- Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapyClinical Immunology, 2010
- Conserved HIV‐1 Epitopes Continuously Elicit Subdominant Cytotoxic T‐Lymphocyte ResponsesThe Journal of Infectious Diseases, 2009
- Rare HLA Drive Additional HIV Evolution Compared to More Frequent AllelesAIDS Research and Human Retroviruses, 2009
- Dendritic cell‐based human immunodeficiency virus vaccineJournal of Internal Medicine, 2008
- Chronic innate immune activation as a cause of HIV-1 immunopathogenesisPublished by Elsevier ,2007
- Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responsesThe Journal of Experimental Medicine, 2007
- Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged MonkeysScience, 2006
- Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challengeThe Journal of Experimental Medicine, 2006